Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04494880 · ClinicalTrials.gov registry record · Early Phase 1
Marcaine Post-Operative Pain Study
A Early Phase 1 study, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 22
- Enrollment target
NCT04494880 is a Early Phase 1 study that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 22 participants.
The verdict
NCT04494880, a Early Phase 1 study, has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The study examines the efficacy of Marcaine in post-operative pain reduction for patients receiving breast reduction surgery. Patients who consent will be randomized to which breast receives a Marcaine injection and the other breast will have saline injected. Pain will be assessed one time post-operatively using a 1-10 pain scale.
Interventions
- DRUG Bupivacaine Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-12-09 |
| Est. Completion | 2022-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04494880
The ClinicalTrials.gov registry entry for NCT04494880 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bupivacaine Injection is the first listed.
NCT04494880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04494880 about?
NCT04494880 is a clinical study titled "Marcaine Post-Operative Pain Study". The study examines the efficacy of Marcaine in post-operative pain reduction for patients receiving breast reduction surgery. Patients who consent will be randomized to which breast receives a Marcaine injection and the other breast will have saline injected. Pain will be assessed one time post-oper...
What is the current status of trial NCT04494880?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 22 participants. The study started on 2020-12-09. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04494880?
The interventions under investigation include: Bupivacaine Injection (DRUG).
Who is sponsoring clinical trial NCT04494880?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.